Profiel
Xiao Ping Dai is currently the Chief Technical Officer at IVERIC bio, Inc. Prior to this, she worked as the Senior Director-Biologics Development at Celgene Corp.
from 2014 to 2018, and as the Chief Technologist & VP-Technology Development at WuXi Advanced Therapies, Inc. from 2018 to 2019.
She holds a doctorate degree from the New Jersey Institute of Technology.
Actieve functies van Xiao Ping Dai
| Bedrijven | Functie | Begin |
|---|---|---|
| IVERIC BIO, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van Xiao Ping Dai
| Bedrijven | Functie | Einde |
|---|---|---|
WuXi Advanced Therapies, Inc.
WuXi Advanced Therapies, Inc. BiotechnologyHealth Technology Engages in development, testing, manufacturing and commercialization of cell & gene therapies | Hoofd Techniek/Wetenschap/O&O | 01-10-2019 |
| CELGENE | Corporate Officer/Principal | 01-06-2018 |
Opleiding van Xiao Ping Dai
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
New Jersey Institute of Technology
New Jersey Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IVERIC bio, Inc.
IVERIC bio, Inc. BiotechnologyHealth Technology Operates as a science-driven biopharmaceutical company that develops novel treatments for retinal diseases | Health Technology |
WuXi Advanced Therapies, Inc.
WuXi Advanced Therapies, Inc. BiotechnologyHealth Technology Engages in development, testing, manufacturing and commercialization of cell & gene therapies | Health Technology |
















